AstraZeneca, Daiichi Sankyo get Orphan Drug Designation for gastric cancer drug Enhertu Ruchika Sharma25 May 2020 11:56 AM ISTUS: Daiichi Sankyo Company Limited and AstraZeneca's Enhertu (trastuzumab deruxtecan) has been granted Orphan Drug Designation (ODD) in the US for the...
AstraZeneca secures orders for 400 million doses of COVID-19 vaccine Ruchika Sharma24 May 2020 11:15 AM ISTLondon: Drugmaker AstraZeneca secured its first agreements Thursday for 400 million doses of a COVID-19 vaccine, bolstered by an investment from the...
AstraZeneca receives 1 Billion USD investment for Oxford vaccine MD Bureau22 May 2020 10:45 AM ISTThe deal includes a Phase III clinical trial with 30,000 participants and a paediatric trial.
AstraZeneca, Daiichi Sankyo get USFDA Breakthrough Therapy status for lung cancer drug Enhertu Ruchika Sharma19 May 2020 12:32 PM ISTUK: AstraZeneca and Daiichi Sankyo Company, Limited has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment of patients...
Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020 for emergency use Ruchika Sharma3 May 2020 12:00 PM ISTZurich/Geneva: Pfizer aims to make 10-20 million doses of a coronavirus vaccine it is developing with Germany's BioNtech by the end of 2020 for...
AstraZeneca ink pact with Oxford University to develop, distribute COVID-19 vaccine ChAdOx1 nCoV-19 Ruchika Sharma3 May 2020 11:00 AM ISTUK: AstraZeneca and the University of Oxford have announced an agreement for the global development and distribution of the University's potential...
Glenmark Pharmaceuticals gets USFDA Tentative nod for Dapagliflozin, Saxagliptin Tablets Ruchika Sharma29 April 2020 4:14 PM ISTMumbai: Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the United States Food & Drug Administration for Dapagliflozin...
Positive results of phase III PROfound trial of Lynparza for metastatic castration-resistant prostate cancer: AstraZeneca, MSD Ruchika Sharma26 April 2020 9:00 AM ISTUS: AstraZeneca and MSD Inc. has announced further positive results from the Phase III PROfound trial of Lynparza (olaparib) in men with metastatic...
Seven pharma giants join Parkinsons consortium savita25 Feb 2016 12:45 PM ISTAstraZeneca, Pfizer and Eli Lilly are among seven major pharmaceutical companies linking into a “ground-breaking” consortium striving to streamline...
AstraZeneca wins FDA breakthrough status for durvalumab savita18 Feb 2016 9:16 AM ISTLONDON: The U.S. Food and Drug Administration has granted breakthrough therapy designation to AstraZeneca's biggest new drug hope durvalumab as a...
GSK, Astra, J&J link with universities in new drug research fund savita26 Jan 2016 9:29 AM ISTLondon : GlaxoSmithKline, AstraZeneca and Johnson & Johnson have joined with three leading British universities to create a new 40 million pounds...
Sanofi deepens cancer drive with two deals worth $1.2 billion, Innate jumps savita12 Jan 2016 9:24 AM ISTParis: Sanofi boosted its presence in cancer research by signing two deals with biotech companies worth up to $1.2 billion, as the French drugmaker...
